|
|
||||||||
140 on Long-Term Potentiation in the Rat Hippocampal CA1 Region In Vivo
Department of Human Anatomy and Physiology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 2, Ireland
Submitted 1 November 2002; accepted in final form 6 January 2003
Hippocampal long-term potentiation (LTP) is a form of synaptic plasticity used as a cellular model of memory. Beta amyloid (A
) is involved in Alzheimer's disease (AD), a neurode-generative disorder leading to cognitive deficits. Nicotine is also claimed to act as a cognitive enhancer. A
is known to bind with high affinity to the
7-nicotinic acetylcholine receptor (nAChR). Here we have investigated the effect of intracerebroventricular (icv) injection of the endogenous peptide A
140 on LTP in area CA1 of urethananesthetized rats. We also examined the effect of A
1228 (icv), which binds with high affinity to the
7-nAChR and the specific
7-nAChR antagonist methyllycaconitine (MLA) on LTP. We found that A
1228 had no effect on LTP, whereas MLA depressed significantly LTP, suggesting that activation of the
7-nAChR is a requirement for LTP. Within the in vivo environment, where other factors may compete with A
1228 for binding to
7-nAChR, it does not appear to modulate LTP. To determine if the depressive action of A
140 on LTP could be modulated by nicotine, these agents were also co-applied. Injection of 1 or 10 nmol A
140 caused a significant depression of LTP, whereas nicotine alone (3 mg/kg) had no effect on LTP. Co-injection of nicotine with A
140 1 h prior to LTP induction caused a further significant depression of LTP compared with A
140 alone. These results demonstrate that nicotine enhances the deficit in LTP produced by A
140. This then suggests that nicotine may exacerbate the depressive actions of A
on synaptic plasticity in AD.
This article has been cited by other articles:
![]() |
J R. PAULY, C M. CHARRIEZ, M V. GUSEVA, and S W. SCHEFF Nicotinic Receptor Modulation for Neuroprotection and Enhancement of Functional Recovery Following Brain Injury or Disease Ann. N.Y. Acad. Sci., December 1, 2004; 1035(1): 316 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Minogue, A. W. Schmid, M. P. Fogarty, A. C. Moore, V. A. Campbell, C. E. Herron, and M. A. Lynch Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-{beta} on Long Term Potentiation and Cell Death in Hippocampus: A ROLE FOR INTERLEUKIN-1{beta}? J. Biol. Chem., July 18, 2003; 278(30): 27971 - 27980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Freir, D. A. Costello, and C. E. Herron A{beta}25-35-Induced Depression of Long-Term Potentiation in Area CA1 In Vivo and In Vitro Is Attenuated by Verapamil J Neurophysiol, June 1, 2003; 89(6): 3061 - 3069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |